Literature DB >> 18504425

Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration.

N S Tannu1, L L Howell, S E Hemby.   

Abstract

The reinforcing effects and long-term consequences of cocaine self-administration have been associated with brain regions of the mesolimbic dopamine pathway, namely the nucleus accumbens (NAc). Studies of cocaine-induced biochemical adaptations in rodent models have advanced our knowledge; however, unbiased detailed assessments of intracellular alterations in the primate brain are scarce, yet essential, to develop a comprehensive understanding of cocaine addiction. To this end, two-dimensional difference in gel electrophoresis (2D-DIGE) was used to compare changes in cytosolic protein abundance in the NAc between rhesus monkeys self-administering cocaine and controls. Following image normalization, spots with significantly differential image intensities (P<0.05) were identified, excised, trypsin digested and analyzed by matrix-assisted laser-desorption ionization time-of-flight time-of-flight (MALDI-TOF-TOF). In total, 1098 spots were subjected to statistical analysis with 22 spots found to be differentially abundant of which 18 proteins were positively identified by mass spectrometry. In addition, approximately 1000 protein spots were constitutively expressed of which 21 proteins were positively identified by mass spectrometry. Increased levels of proteins in the cocaine-exposed monkeys include glial fibrillary acidic protein, syntaxin-binding protein 3, protein kinase C isoform, adenylate kinase isoenzyme 5 and mitochondrial-related proteins, whereas decreased levels of proteins included beta-soluble N-ethylmaleimide-sensitive factor attachment protein and neural and non-neural enolase. Using a complimentary proteomics approach, the differential expression of phosphorylated proteins in the cytosolic fraction of these subjects was examined. Two-dimensional gel electrophoresis (2DGE) was followed by gel staining with Pro-Q Diamond phosphoprotein gel stain, enabling differentiation of approximately 150 phosphoprotein spots between the groups. Following excision and trypsin digestions, MALDI-TOF-TOF was used to confirm the identity of 15 cocaine-altered phosphoproteins. Significant increased levels were detected for gamma-aminobutyric acid type A receptor-associated protein 1, 14-3-3 gamma-protein, glutathione S-transferase and brain-type aldolase, whereas significant decreases were observed for beta-actin, Rab GDP-dissociation inhibitor, guanine deaminase, peroxiredoxin 2 isoform b and several mitochondrial proteins. Results from these studies indicate coordinated dysregulation of proteins related to cell structure, signaling, metabolism and mitochondrial function. These data extend and compliment previous studies of cocaine-induced biochemical alterations in human postmortem brain tissue, using an animal model that closely recapitulates the human condition and provide new insight into the molecular basis of the disease and potential targets for pharmacotherapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18504425      PMCID: PMC3272768          DOI: 10.1038/mp.2008.53

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  76 in total

Review 1.  Microarray studies of psychostimulant-induced changes in gene expression.

Authors:  Vadim Yuferov; David Nielsen; Eduardo Butelman; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2005-03       Impact factor: 4.280

2.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

Review 3.  Assessment of genome and proteome profiles in cocaine abuse.

Authors:  Scott E Hemby
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

4.  Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neurofilaments. Early turnover during axonal transport.

Authors:  R K Sihag; R A Nixon
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

5.  Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse.

Authors:  Minoru Narita; Mayumi Miyatake; Michiko Narita; Masahiro Shibasaki; Keiko Shindo; Atsushi Nakamura; Naoko Kuzumaki; Yasuyuki Nagumo; Tsutomu Suzuki
Journal:  Neuropsychopharmacology       Date:  2006-01-11       Impact factor: 7.853

Review 6.  Mammalian class theta GST and differential susceptibility to carcinogens: a review.

Authors:  S Landi
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

Review 7.  Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.

Authors:  Sue Goo Rhee; Ho Zoon Chae; Kanghwa Kim
Journal:  Free Radic Biol Med       Date:  2005-03-24       Impact factor: 7.376

8.  Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area.

Authors:  D Beitner-Johnson; X Guitart; E J Nestler
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

9.  Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens.

Authors:  M J Miserendino; E J Nestler
Journal:  Brain Res       Date:  1995-03-20       Impact factor: 3.252

10.  Enhanced detergent extraction for analysis of membrane proteomes by two-dimensional gel electrophoresis.

Authors:  Matthew A Churchward; R Hussain Butt; John C Lang; Kimberly K Hsu; Jens R Coorssen
Journal:  Proteome Sci       Date:  2005-06-07       Impact factor: 2.480

View more
  14 in total

1.  AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis.

Authors:  Kathryn J Reissner; Joachim D Uys; John H Schwacke; Susanna Comte-Walters; Jennifer L Rutherford-Bethard; Thomas E Dunn; Joe B Blumer; Kevin L Schey; Peter W Kalivas
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 2.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

Review 3.  Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses.

Authors:  Ju Wang; Wenji Yuan; Ming D Li
Journal:  Mol Neurobiol       Date:  2011-09-16       Impact factor: 5.590

4.  Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.

Authors:  William C Buchta; Aubin Moutal; Bethany Hines; Constanza Garcia-Keller; Alexander C W Smith; Peter Kalivas; Rajesh Khanna; Arthur C Riegel
Journal:  Mol Neurobiol       Date:  2019-07-29       Impact factor: 5.590

Review 5.  Glutamate and Brain Glutaminases in Drug Addiction.

Authors:  Javier Márquez; José A Campos-Sandoval; Ana Peñalver; José M Matés; Juan A Segura; Eduardo Blanco; Francisco J Alonso; Fernando Rodríguez de Fonseca
Journal:  Neurochem Res       Date:  2016-12-23       Impact factor: 3.996

Review 6.  Cocainomics: new insights into the molecular basis of cocaine addiction.

Authors:  Scott E Hemby
Journal:  J Neuroimmune Pharmacol       Date:  2010-03       Impact factor: 4.147

Review 7.  The use of neuroproteomics in drug abuse research.

Authors:  Melinda E Lull; Willard M Freeman; Heather D VanGuilder; Kent E Vrana
Journal:  Drug Alcohol Depend       Date:  2009-11-17       Impact factor: 4.492

8.  Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine.

Authors:  Amy C Boudreau; Carrie R Ferrario; Marc J Glucksman; Marina E Wolf
Journal:  J Neurochem       Date:  2009-05-03       Impact factor: 5.372

9.  Mass spectrometry screening reveals peptides modulated differentially in the medial prefrontal cortex of rats with disparate initial sensitivity to cocaine.

Authors:  Elena V Romanova; Ji Eun Lee; Neil L Kelleher; Jonathan V Sweedler; Joshua M Gulley
Journal:  AAPS J       Date:  2010-05-19       Impact factor: 4.009

Review 10.  Biomarkers for the development of new medications for cocaine dependence.

Authors:  Kristopher J Bough; Shashi Amur; Guifang Lao; Scott E Hemby; Nilesh S Tannu; Kyle M Kampman; Joy M Schmitz; Diana Martinez; Kalpana M Merchant; Charles Green; Jyoti Sharma; Anne H Dougherty; F Gerard Moeller
Journal:  Neuropsychopharmacology       Date:  2013-08-27       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.